About Instituto Clinico Quirurgico de Oftalmologia
"Centro oftalmológico de referencia ubicado desde mayo de 2021 en Indautxu tras haber estado más de 25 años en Begoña. Con más de 20 oftalmólogos especializados en las distintas partes del ojo, ofrecen un servicio de atención integral en todo lo relacionado con la salud ocular. Para ello, el centro cuenta con quirófanos oftalmológicos y de cirugía refractiva, laboratorio, área de consultas y servicio de urgencias."
Clinical Trials at Instituto Clinico Quirurgico de Oftalmologia
During the past decade, Instituto Clinico Quirurgico de Oftalmologia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instituto Clinico Quirurgico de Oftalmologia" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "IVERIC bio, Inc." with 1 trials
sponsored, "Kodiak Sciences Inc" with 1 trials sponsored, "NicOx" with 1 trials sponsored and "Oxurion"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Instituto Clinico Quirurgico de Oftalmologia
According to Clinical.Site data, the most researched conditions in "Instituto Clinico Quirurgico de Oftalmologia" are
"Geographic Atrophy" (3 trials), "Diabetes Mellitus" (1 trials), "Diabetic Macular Edema" (1 trials), "Diabetic Retinopathy" (1 trials) and "Macular Degeneration" (1 trials). Many other conditions were trialed in "Instituto Clinico Quirurgico de Oftalmologia" in a lesser frequency.
Clinical Trials Intervention Types at Instituto Clinico Quirurgico de Oftalmologia
Most popular intervention types in "Instituto Clinico Quirurgico de Oftalmologia" are "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Lampalizumab" (2 trials), "Sham" (2 trials), "Aflibercept" (1 trials), "Aflibercept 2mg" (1 trials) and "KSI-301" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto Clinico Quirurgico de Oftalmologia
The vast majority of trials in "Instituto Clinico Quirurgico de Oftalmologia" are
6 trials for "All" genders.
Clinical Trials Status at Instituto Clinico Quirurgico de Oftalmologia
Currently, there are NaN active trials in "Instituto Clinico Quirurgico de Oftalmologia".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Instituto Clinico Quirurgico de Oftalmologia,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Clinico Quirurgico de Oftalmologia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".